Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Total Non-Current Liabilities: 2010-2025

Historic Total Non-Current Liabilities for Altimmune (ALT) over the last 13 years, with Sep 2025 value amounting to $27.1 million.

  • Altimmune's Total Non-Current Liabilities rose 362.49% to $27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.1 million, marking a year-over-year increase of 362.49%. This contributed to the annual value of $5.3 million for FY2024, which is 21.19% up from last year.
  • According to the latest figures from Q3 2025, Altimmune's Total Non-Current Liabilities is $27.1 million, which was up 14.86% from $23.6 million recorded in Q2 2025.
  • Altimmune's 5-year Total Non-Current Liabilities high stood at $27.1 million for Q3 2025, and its period low was $4.1 million during Q1 2024.
  • In the last 3 years, Altimmune's Total Non-Current Liabilities had a median value of $5.5 million in 2024 and averaged $10.2 million.
  • In the last 5 years, Altimmune's Total Non-Current Liabilities slumped by 66.41% in 2022 and then spiked by 362.49% in 2025.
  • Quarterly analysis of 5 years shows Altimmune's Total Non-Current Liabilities stood at $13.6 million in 2021, then plummeted by 66.41% to $4.6 million in 2022, then dropped by 3.99% to $4.4 million in 2023, then climbed by 21.19% to $5.3 million in 2024, then surged by 362.49% to $27.1 million in 2025.
  • Its Total Non-Current Liabilities was $27.1 million in Q3 2025, compared to $23.6 million in Q2 2025 and $5.3 million in Q1 2025.